{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:40:12Z","timestamp":1775151612407,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of the Basque Country UPV\/EHU","award":["UFI11\/32"],"award-info":[{"award-number":["UFI11\/32"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.06.096","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T15:22:09Z","timestamp":1373296929000},"page":"4069-4078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The state-of-the-art of approved and under-development cholera vaccines"],"prefix":"10.1016","volume":"31","author":[{"given":"M.","family":"Pastor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Pedraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Esquisabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.06.096_bib0005","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/S0140-6736(12)60436-X","article-title":"Cholera","volume":"379","author":"Harris","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2471\/BLT.11.093427","article-title":"The global burden of cholera","volume":"90","author":"Ali","year":"2012","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera","volume":"363","author":"Sack","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cir141","article-title":"Oral vaccines against cholera","volume":"52","author":"Shin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/CMR.8.1.48","article-title":"Cholera","volume":"8","author":"Kaper","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00013542-199601000-00005","article-title":"Vibrio cholerae O139 Bengal: the new serogroup causing cholera","volume":"7","author":"Nair","year":"1996","journal-title":"Rev Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1995-7645(11)60149-1","article-title":"Cholera: a great global concern","volume":"4","author":"Mandal","year":"2011","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0040","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1073\/pnas.84.9.2833","article-title":"Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin","volume":"84","author":"Taylor","year":"1987","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/path.1700630417","article-title":"An experimental study of the action of cholera toxin","volume":"63","author":"De","year":"1951","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0014-5793(92)81398-6","article-title":"The second cholera toxin, Zot, and its plasmid-encoded and phage-encoded homologues constitute a group of putative ATPases with an altered purine NTP-binding motif","volume":"312","author":"Koonin","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0055","first-page":"209","article-title":"Biological activity of recombinant accessory cholerae enterotoxin (ace) on rabbit ileal loops and antibacterial assay","volume":"14","author":"Anvari","year":"2012","journal-title":"Cell J"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(84)90006-0","article-title":"Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin","volume":"323","author":"O\u2019Brien","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-5793(93)81766-S","article-title":"Purification and sequence determination of heat-stable enterotoxin elaborated by a cholera toxin-producing strain of Vibrio cholerae O1","volume":"326","author":"Yoshino","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1574-695X.1996.tb00272.x","article-title":"Development of an improved synthetic medium for a better production of the new cholera toxin and its immunological relationship with the toxin produced by Vibrio cholerae O139 strains","volume":"14","author":"Tikoo","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0882-4010(95)90076-4","article-title":"Distribution of genes encoding cholera toxin, zonula occludens toxin, accessory cholera toxin, and El Tor hemolysin Vibrio cholerae of diverse origins","volume":"18","author":"Kurazono","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(07)70138-X","article-title":"The true burden and risk of cholera: implications for prevention and control","volume":"7","author":"Zuckerman","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/infdis\/129.1.45","article-title":"Response of man to Infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum","volume":"129","author":"Cash","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/313951","article-title":"Cholera vaccines","volume":"31","author":"Ryan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1574-6968.1999.tb08786.x","article-title":"How Vibrio cholerae survive during starvation","volume":"180","author":"Wai","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0100","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/QCO.0b013e32834a88af","article-title":"Cholera in the 21st century","volume":"24","author":"Charles","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0105","series-title":"State of the art of vaccine research and development","author":"WHO Department of Immunization, Vaccines and Biologicals","year":"2009"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.4.2.5122","article-title":"Cholera vaccines for the developing world","volume":"4","author":"Lopez","year":"2008","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0115","first-page":"225","article-title":"Antimicrobials & cholera: are we stranded","volume":"133","author":"Ghosh","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0120","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1016\/j.vaccine.2010.05.008","article-title":"Cholera vaccines: WHO position paper-recommendations","volume":"28","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0125","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.meegid.2011.08.020","article-title":"Vibrio cholerae O1 lineages driving cholera outbreaks during seventh cholera pandemic in Ghana","volume":"11","author":"Thompson","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0130","first-page":"289","article-title":"Cholera 2011","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0135","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(12)60832-0","article-title":"Oral cholera vaccine and integrated cholera control in Haiti","volume":"379","author":"Ivers","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0140","series-title":"Cholera: mechanism for control and prevention","author":"64th World Health Assembly","year":"2011"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0145","series-title":"WHO Technical Working Group on creation of an oral cholera vaccine stockpile","author":"Control of Epidemic Diseases (CED) Unit in the Department of Pandemic and Epidemic Diseases (PED), of the Health Security and Environment (HSE) cluster at World Health Organization (WHO)","year":"2012"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0150","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1586\/erv.09.137","article-title":"Development of Peru-15 (CholeraGarde\u00ae), a live-attenuated oral cholera vaccine: 1991\u20132009","volume":"8","author":"Chowdhury","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0155","series-title":"La inoculaci\u00f3n preventiva contra el colera morbo asiatico","author":"Ferran","year":"1886"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0160","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(02)00528-7","article-title":"Injections against cholera: a lecture","volume":"141","author":"Haffkine","year":"1893","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0165","first-page":"1165","article-title":"Annotations","volume":"225","author":"Kolle","year":"1935","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0170","series-title":"Cholera Fact Sheet num 107","first-page":"107","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0175","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2003.12.033","article-title":"Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR","volume":"22","author":"Viret","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/14760584.5.4.483","article-title":"Live attenuated oral cholera vaccines","volume":"5","author":"Ryan","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0185","series-title":"Draft document to be presented to WHO SAGE in October 2009","article-title":"Background paper on the integration of oral cholera vaccines into global cholera control programmes","author":"Abramson","year":"2009"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0190","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0195","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.vaccine.2005.10.014","article-title":"A review of vaccine research and development: human enteric infections","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children","volume":"340","author":"Suharyono","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0205","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1016\/j.vaccine.2005.05.022","article-title":"Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers\u2019 diarrhoea in a randomised, double-blind, placebo-controlled study","volume":"23","author":"Leyten","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0210","first-page":"63","article-title":"A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali","volume":"76","author":"Perry","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0215","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.vaccine.2005.07.015","article-title":"Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638","volume":"24","author":"Talavera","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/IAI.67.2.539-545.1999","article-title":"Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin\/protease-defective El Tor Strain as a cholera vaccine candidate","volume":"67","author":"Benitez","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0225","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1016\/j.vaccine.2009.08.042","article-title":"Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults","volume":"27","author":"Valera","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/432074","article-title":"Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh","volume":"192","author":"Qadri","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0240","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.vaccine.2009.05.065","article-title":"Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1. 3 for safety and immune response","volume":"27","author":"Mahalanabis","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0245","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1128\/IAI.71.10.5498-5504.2003","article-title":"Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108","volume":"71","author":"Liang","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0250","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.micinf.2012.04.004","article-title":"TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera","volume":"14","author":"Led\u00f3n","year":"2012","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0255","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1016\/j.vaccine.2005.07.016","article-title":"Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation","volume":"24","author":"Ravichandran","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/172.3.883","article-title":"Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge","volume":"172","author":"Tacket","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0265","first-page":"244","article-title":"Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO","volume":"25","author":"Chaignat","year":"2007","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0270","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","article-title":"Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0275","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.coi.2009.04.002","article-title":"New horizon of mucosal immunity and vaccines","volume":"21","author":"Takahashi","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tmaid.2007.09.004","article-title":"Immunisation of the travelling child","volume":"5","author":"Giovanetti","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1473-3099(07)70032-4","article-title":"Cholera vaccines","volume":"7","author":"Kabir","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","article-title":"Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up","volume":"14","author":"van Loon","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0295","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0300","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(06)70494-7","article-title":"Oral cholera vaccines: use in clinical practice","volume":"6","author":"Hill","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0305","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.vaccine.2008.12.041","volume":"27","author":"Shamsuzzaman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0310","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bpg.2003.11.004","article-title":"Progress in enteric vaccine development","volume":"18","author":"Svennerholm","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0315","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","article-title":"Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam","volume":"24","author":"Thiem","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0320","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0330","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0335","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14760584.7.4.431","article-title":"Cholera in disasters: do vaccines prompt new hopes","volume":"7","author":"Chaignat","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0340","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejpb.2011.06.009","article-title":"Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation","volume":"79","author":"Borde","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0345","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.vaccine.2005.12.064","article-title":"Formulation in tablets of a cholera whole cells inactivated vaccine candidate","volume":"24","author":"Talavera","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0350","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1016\/j.vaccine.2011.02.074","article-title":"Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats","volume":"29","author":"L\u00f3pez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/181646","article-title":"An overview on the field of micro- and nanotechnologies for synthetic peptide-based vaccines","volume":"2011","author":"Salvador","year":"2011","journal-title":"J Drug Delivery"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0360","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0300-9084(02)00028-7","article-title":"Quality control of biotechnology-derived vaccines: technical and regulatory considerations","volume":"84","author":"Fuchs","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0365","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2011.12.039","article-title":"Towards tailored vaccine delivery: needs, challenges and perspectives","volume":"161","author":"Amorij","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0370","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.0706296105","article-title":"Antigen kinetics determines immune reactivity","volume":"105","author":"Johansen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0375","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0380","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0264-410X(00)00083-9","article-title":"Passive protection of serum from volunteers inoculated with attenuated strain 638 of Vibrio cholerae O1 in animal models","volume":"19","author":"P\u00e9rez","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0385","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/CDLI.6.6.812-818.1999","article-title":"Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera","volume":"6","author":"Qadri","year":"1999","journal-title":"ClinDiagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0390","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-3659(02)00140-2","article-title":"Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles","volume":"82","author":"Yeh","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0395","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1016\/j.vaccine.2011.05.098","article-title":"A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae","volume":"29","author":"A\u00f1o","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0400","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2013.02.057","article-title":"An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles","volume":"448","author":"Pastor","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0405","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1099\/jmm.0.020875-0","article-title":"Immunological efficacy of glycoconjugates derived from Vibrio cholerae O1 serotype Ogawa detoxified LPS in mice","volume":"59","author":"Paulovicova","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0410","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.vaccine.2008.10.052","article-title":"A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB\/c mice","volume":"27","author":"P\u00e9rez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymeth.2009.03.027","article-title":"Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice","volume":"49","author":"Acevedo","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0420","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.vaccine.2009.07.071","article-title":"Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity","volume":"27","author":"Yuki","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0425","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.vaccine.2009.11.025","article-title":"FDA guidance on prophylactic DNA vaccines: analysis and recommendations","volume":"28","author":"Klinman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.096_bib0430","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/j.vaccine.2009.04.008","article-title":"Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera","volume":"27","author":"Xu","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13009067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13009067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T02:02:03Z","timestamp":1596074523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13009067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":86,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13009067"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.096","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The state-of-the-art of approved and under-development cholera vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}